Skip to content

Interest of Cryotherapy or Cortisone Aerosol Therapy in Early Post-operative Swallowing Disorders Following Total Thyroidectomy

Interest of Cryotherapy or Cortisone Aerosol Therapy in Early Post-operative Swallowing Disorders Following Total Thyroidectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02855866
Acronym
DEGLUTHYR
Enrollment
240
Registered
2016-08-04
Start date
2013-09-03
Completion date
2015-02-20
Last updated
2018-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroidectomy, Post-operative Swallowing Disorders

Brief summary

The scientific interest of this study is to improve post-operative comfort in patients after thyroid surgery using simple, inexpensive techniques. The investigator expects that local applications of ice or cortisone aerosols will reduce swallowing discomfort and control post-operative pain (POP). The investigator hopes that local cryotherapy will decrease post-operative oedema (vasoconstriction) and the volume of liquid drained (action on the serous fluid at the site of the thyroidectomy).

Interventions

PROCEDUREthyroidectomy
OTHERcryotherapy
DRUGcortisone aerosol
DRUGparacetamol

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients about to undergo total thyroidectomy by cervicotomy * Single surgeon: Dr Osmak-Tizon Liliana * Patients who have provided written consent to take part in the research * Hospitalized in the endocrine surgery unit * Whose mental and physical state allows them to participate in the quantification of a symptom using a Visual Analogue Scale(VAS)

Exclusion criteria

* Patients under 18 or adults under guardianship * Patients about to undergo unilateral thyroid surgery (thyroid lobectomy) * Patient who have had parathyroid surgery * History of cervicotomy * Intolerance to, contra-indication for or allergy to any of the treatments tested. * Pregnant or breast-feeding women * Patients without national health insurance cover

Design outcomes

Primary

MeasureTime frame
Swallowing Impairment Score (SIS).Evolution of the SIS from baseline (inclusion), to the end of the surgery and every day thereafter until discharge of the patient(up to 3 months)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026